Tim Goodnow

Tim Goodnow is the President and Chief Executive Officer of Senseonics Holdings, Inc., a position he has held since December 2015. He initially joined the company as a board member in December 2010 and has been instrumental in its leadership and strategic direction since then.125

Professional Background

• Senseonics Holdings, Inc.: Goodnow has been serving as President and CEO since 2015, overseeing the company's focus on developing innovative glucose monitoring systems for diabetes management.
• Abbott Diabetes Care: Prior to joining Senseonics, he was the Divisional Vice President of Technical Operations at Abbott Diabetes Care from 2000 to 2011, where he contributed to advancements in diabetes care technologies.
• TheraSense: He served as Vice President of R&D from 2000 to 2004, focusing on research and development in medical devices.
• Verax Biomedical, Inc.: Goodnow was a Founder and VP of R&D from 1998 to 2000.
• Baxter Healthcare: He spent 14 years at Baxter as VP of R&D, gaining extensive experience in medical device development.123

Education

Goodnow earned his Ph.D. in Chemistry from the University of Miami, where he also completed his undergraduate studies.12

Financial Overview

As of early 2022, Tim Goodnow's estimated net worth was approximately $5.2 million, with a significant portion derived from his role at Senseonics, where his total compensation was reported to be around $2.2 million annually.24

Goodnow's extensive experience in the medical device industry, particularly in diabetes care, positions him as a key figure in advancing technologies that improve patient outcomes.